PunjiPUNJI
Live AI ↗
Pharmaceuticals & BiotechnologyMid Cap

Alkem Laboratories Limited

ALKEM · ISIN: INE540L01014

Constituent of NIFTY 100 TRI (0.20%), NIFTY 500 TRI (0.17%), NIFTY LMC 250 TRI (0.40%), NIFTY MC 150 TRI (0.81%)

Close (as of 2026-09-08)
₹5181
-1.17% today
Day Range
₹5129.5 - ₹5206.5
Quality Score (as of 2026-06-30)
63.6/100

Earnings (TTM)

CHART

Alkem Laboratories Limited - revenue & profit (TTM)

Trailing-twelve-month figures by reported quarter, in ₹ Cr. Latest quarter: 2026-06-30.

0 Cr422276 Cr844552 Cr1266828 Cr1689103 CrQ2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026Q4 FY2026Q1 FY2027
Revenue (TTM)PAT (TTM)

20.22%

EBITDA Margin (TTM)

180.44

EPS (TTM)

4.55%

EPS Growth (5Y)

15.81%

EPS Growth (10Y)

Technicals

33.76

RSI (14)

5512.14

SMA (50)

5519.68

SMA (200)

32.61

ADX (14)

5933.5

52-Week High

5075

52-Week Low

-1.25%

1Y Return

73.8982

Avg Traded Value (20D, ₹Cr)

As of 2026-09-08.

Shareholding Pattern

CHART

Shareholding by category

As of 2026-06-30.

49.7%50.3%TOP 2100%
Promoter 49.7%Public 50.3%

F&O Sentiment

Nearest expiry: 2026-09-29 · As of 2026-09-07.

0.5972

PCR (OI)

0.4428

PCR (Volume)

5250

Max Pain Strike

Corporate Actions

No corporate actions on record for this stock.

Recent Deals

No recent block/bulk/short-sell deals on record for this stock.

Stock data · Not financial advice · Past performance does not indicate future returns